116 related articles for article (PubMed ID: 28978087)
1.
Kimura A; Kitamura K; Ailiken G; Satoh M; Minamoto T; Tanaka N; Nomura F; Matsushita K
Oncotarget; 2017 Sep; 8(40):67955-67965. PubMed ID: 28978087
[TBL] [Abstract][Full Text] [Related]
2. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract][Full Text] [Related]
3. [Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
[TBL] [Abstract][Full Text] [Related]
4. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
[TBL] [Abstract][Full Text] [Related]
5. NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.
Gu Z; Xia J; Xu H; Frech I; Tricot G; Zhan F
J Hematol Oncol; 2017 Jan; 10(1):17. PubMed ID: 28086949
[TBL] [Abstract][Full Text] [Related]
6. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
7. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.
David CJ; Chen M; Assanah M; Canoll P; Manley JL
Nature; 2010 Jan; 463(7279):364-8. PubMed ID: 20010808
[TBL] [Abstract][Full Text] [Related]
8. The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress.
Masaki S; Hashimoto K; Kihara D; Tsuzuki C; Kataoka N; Suzuki K
Biochem Biophys Res Commun; 2020 Jun; 526(4):973-977. PubMed ID: 32295714
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Ser6 in hnRNPA1 by S6K2 regulates glucose metabolism and cell growth in colorectal cancer.
Sun Y; Luo M; Chang G; Ren W; Wu K; Li X; Shen J; Zhao X; Hu Y
Oncol Lett; 2017 Dec; 14(6):7323-7331. PubMed ID: 29344170
[TBL] [Abstract][Full Text] [Related]
10. Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells.
Yu L; Teoh ST; Ensink E; Ogrodzinski MP; Yang C; Vazquez AI; Lunt SY
Cancer Metab; 2019; 7():13. PubMed ID: 31893043
[TBL] [Abstract][Full Text] [Related]
11. Base editing-mediated perturbation of endogenous PKM1/2 splicing facilitates isoform-specific functional analysis in vitro and in vivo.
Lin J; Wu S; Shen Q; Liu J; Huang S; Peng G; Qiao Y
Cell Prolif; 2021 Aug; 54(8):e13096. PubMed ID: 34240779
[TBL] [Abstract][Full Text] [Related]
12. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis.
Zahra K; Dey T; Ashish ; Mishra SP; Pandey U
Front Oncol; 2020; 10():159. PubMed ID: 32195169
[TBL] [Abstract][Full Text] [Related]
14. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.
Chen M; Zhang J; Manley JL
Cancer Res; 2010 Nov; 70(22):8977-80. PubMed ID: 20978194
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.
Kano M; Matsushita K; Rahmutulla B; Yamada S; Shimada H; Kubo S; Hiwasa T; Matsubara H; Nomura F
Gene Ther; 2016 Jan; 23(1):50-6. PubMed ID: 26241176
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
Desai S; Ding M; Wang B; Lu Z; Zhao Q; Shaw K; Yung WK; Weinstein JN; Tan M; Yao J
Oncotarget; 2014 Sep; 5(18):8202-10. PubMed ID: 24077665
[TBL] [Abstract][Full Text] [Related]
17. The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues.
Li L; Cheng S; Yeh Y; Shi Y; Henderson N; Price D; Gu X; Yu X
bioRxiv; 2024 Jan; ():. PubMed ID: 38260443
[TBL] [Abstract][Full Text] [Related]
18. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.
Bluemlein K; Grüning NM; Feichtinger RG; Lehrach H; Kofler B; Ralser M
Oncotarget; 2011 May; 2(5):393-400. PubMed ID: 21789790
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Profiling of Mouse Brain Pyruvate Kinase Binding Proteins: A Hint for Moonlighting Functions of PKM1?
Buneeva O; Kopylov A; Gnedenko O; Medvedeva M; Veselovsky A; Ivanov A; Zgoda V; Medvedev A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108803
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase M1 regulates butyrate metabolism in cancerous colonocytes.
Park B; Kim JY; Riffey OF; Dowker-Key P; Bruckbauer A; McLoughlin J; Bettaieb A; Donohoe DR
Sci Rep; 2022 May; 12(1):8771. PubMed ID: 35610475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
